ENTEROSOMA – EPO 13723129.6
Pool of excipients contained in gastro-resistant tablets designed to bypass the physiological constraints to intestinal absorption due to:
- thickness of mucous secretions.
- cytochrome activity.
- P-glycoprotein action.
- proteolytic hydrolysis.
- low transmucosal flux through tight junctions.
Deliverable active ingredients:
raw materials with poor bioavailability in the intestines.
Examples of application:
- formulation in gastro-resistant tablets to deliver berberine, useful for controlling blood sugar levels and cholesterol.
- formulation in gastro-resistant tablets with curcumin, dry extract with marked anti-inflammatory properties.